ImageneBio, Inc. 8-K

What Happened
ImageneBio, Inc. (IMA) filed a Form 8-K on May 7, 2026 (Item 2.02) to announce its financial results for the quarter ended March 31, 2026. The company attached a press release detailing those results as Exhibit 99.1 to the filing.

Key Details

• Filing date: May 7, 2026 (Form 8-K).
• Reporting item: Item 2.02 — Results of Operations and Financial Condition.
• Period covered: Quarter ended March 31, 2026.
• Exhibit included: 99.1 — Press Release dated May 7, 2026; Exhibit 104 — Cover Page Interactive Data File (Inline XBRL).

Why It Matters
This 8-K is the company’s official disclosure of its most recent quarterly results (earnings/revenue and other financial metrics will be in the attached press release). Retail investors should review Exhibit 99.1 for the specific numbers (revenue, net income/loss, cash position, and any guidance or management commentary) because those details can influence valuation, analyst expectations, and short-term trading decisions. The filing confirms the company has publicly released its Q1 2026 results; no other material items (e.g., executive changes or transactions) were reported in this filing.